Oruka's ORKA-001 shows positive Week 16 interim Phase 2a EVERLAST-A data in moderate-to-severe plaque psoriasis, 63.5% achieve PASI 100, supports once-yearly dosing
https://finviz.com/quote.ashx?t=ORKA&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.